GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Astrana Health Inc (NAS:ASTH) » Definitions » ROE %

Astrana Health (Astrana Health) ROE % : 8.18% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Astrana Health ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Astrana Health's annualized net income for the quarter that ended in Dec. 2023 was $49 Mil. Astrana Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $604 Mil. Therefore, Astrana Health's annualized ROE % for the quarter that ended in Dec. 2023 was 8.18%.

The historical rank and industry rank for Astrana Health's ROE % or its related term are showing as below:

ASTH' s ROE % Range Over the Past 10 Years
Min: -625.02   Med: 8.36   Max: 17.7
Current: 10.55

During the past 13 years, Astrana Health's highest ROE % was 17.70%. The lowest was -625.02%. And the median was 8.36%.

ASTH's ROE % is ranked better than
66.83% of 612 companies
in the Healthcare Providers & Services industry
Industry Median: 4.035 vs ASTH: 10.55

Astrana Health ROE % Historical Data

The historical data trend for Astrana Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astrana Health ROE % Chart

Astrana Health Annual Data
Trend Jan14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.59 -9.09 17.70 9.12 10.50

Astrana Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.83 9.53 9.36 15.22 8.18

Competitive Comparison of Astrana Health's ROE %

For the Medical Care Facilities subindustry, Astrana Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's ROE % distribution charts can be found below:

* The bar in red indicates where Astrana Health's ROE % falls into.



Astrana Health ROE % Calculation

Astrana Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=60.717/( (542.561+614.218)/ 2 )
=60.717/578.3895
=10.50 %

Astrana Health's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=49.424/( (593.714+614.218)/ 2 )
=49.424/603.966
=8.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Astrana Health  (NAS:ASTH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=49.424/603.966
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(49.424 / 1412.144)*(1412.144 / 1003.311)*(1003.311 / 603.966)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.5 %*1.4075*1.6612
=ROA %*Equity Multiplier
=4.93 %*1.6612
=8.18 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=49.424/603.966
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (49.424 / 3.696) * (3.696 / -15.48) * (-15.48 / 1412.144) * (1412.144 / 1003.311) * (1003.311 / 603.966)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 13.3723 * -0.2388 * -1.1 % * 1.4075 * 1.6612
=8.18 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Astrana Health ROE % Related Terms

Thank you for viewing the detailed overview of Astrana Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Astrana Health (Astrana Health) Business Description

Traded in Other Exchanges
Address
1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Executives
Chandan Basho officer: See Remarks 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
John Vong officer: SVP-Chief Accounting Officer 4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740
Linda Marsh director 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Allied Physicians Of California, A Profession Medical Corp 10 percent owner 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Weili Dai, director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
J. Lorraine Estradas director 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
David Schmidt director 700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203
Albert Waichow Young officer: Chief Administrative Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Adrian Vazquez officer: Chief Medical Officer C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Thomas S. Lam director, officer: President and Co-CEO 1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Kenneth T. Sim director, officer: Executive Chairman and Co-CEO 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Brandon Sim director, officer: See Remarks C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
Eric Chin officer: Chief Financial Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Michael F. Eng director 712 BATAAN PLACE, MONTEREY PARK CA 91755
Hing Ang officer: Chief Operating Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801